Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Colchicine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transcatheter Aortic Valve Replacement
1 trial -
Colostrum supplementation for bone loss
Petros Pharmaceuticals
Osteopenia
1 trial -
Compound Norethisterone Enanthate Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contraception Behavior
1 trial -
Control (Standard treatment)
Grace Therapeutics
Moisture Associated Skin Damage
1 trial -
Conventional treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Copd Exacerbation Acute
1 trial -
Coronary Computed Tomography Angiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Adverse Cardiovascular Events (MACE)
1 trial -
Cy-TB test
International Peace Maternity and Child Health Hospital
Latent Tuberculosis
1 trial -
DAOSiN®/ Placebo & ProvokAmin® Ingestion
Century Therapeutics
Histamine Intolerance
1 trial -
ET-01
Guangzhou Virotech Pharmaceutical Co.,
Transfusion Dependent Beta-Thalassaemia
1 trial -
Evaluation of social, cultural and behavioral factors
International Peace Maternity and Child Health Hospital
Cardio-vascular Disease
1 trial -
Exforge HCT® or Three Individual drug amlodipine + valsartan + hydrochlorothiazide
The University of Hong Kong
Intracerebral Hemorrhage
1 trial -
ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules
Biotech Pharmaceutical Co.,
Cognitive Functions Perceptual Disturbances
1 trial -
Experimental
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Cognitive Health
1 trial -
External beam radiotherapy
International Peace Maternity and Child Health Hospital
Squamous Cell Carcinoma of the Head and Neck
1 trial -
Fospropofol (Lusedra®) 6.5
Grace Therapeutics
Interstitial Cystitis
1 trial -
Generic cetrorelix acetate
NORTHWEST BIOTHERAPEUTICS INC
Infertility
1 trial -
Gold omega 3
COLLEGIUM PHARMACEUTICAL, INC
Chronic Kidney Disease
1 trial -
High-amylose maize starch+acetate/butyrate
United Therapeutics Europe Ltd
Aerobic Endurance
1 trial -
Immunological Factors
COLLEGIUM PHARMACEUTICAL, INC
Neuropathic Pain
1 trial -
Inhaled Placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ventilator-Associated Pneumonia (VAP)
1 trial -
Ispaghula
IRONWOOD PHARMACEUTICALS INC
Constipation
1 trial -
Kuvan
BioMarin Pharmaceutical Australia Pty Ltd
Heart Failure
1 trial -
Lactobacillus rhamnosus F-1
Biotech Pharmaceutical Co.,
Allergic Rhinitis
1 trial -
Letrozole
International Peace Maternity and Child Health Hospital
Letrozole
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources